Pelham Eye Center Llc in Pelham, AL - Medicare Optometrist Provider

Pelham Eye Center Llc is a medicare enrolled "Optometrist" provider in Pelham, Alabama. Their current practice location is 200 Canyon Park Dr, Pelham, Alabama. You can reach out to their office (for appointments etc.) via phone at (205) 910-1750.

Pelham Eye Center Llc is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Pelham Eye Center Llc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1487252920.

Contact Information

	Pelham Eye Center Llc
	200 Canyon Park Dr, Pelham, AL 35124-4817
	(205) 910-1750
	Not Available

Healthcare Provider's Profile

Full Name	Pelham Eye Center Llc
Type	Facility
Speciality	Optometrist
Location	200 Canyon Park Dr, Pelham, Alabama
Accepts Medicare Assignments	Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.

NPI Data:

NPI Number: 1487252920
Provider Enumeration Date: 10/16/2020
Last Update Date: 10/16/2020

Medicare PECOS Information:

PECOS PAC ID: 4789094137
Enrollment ID: O20201113001422

Medical Identifiers

Medical identifiers for Pelham Eye Center Llc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1487252920	NPI	-	NPPES
1861708745	Other	AL	NPI
1962561746	Other	AL	NPI

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	(* (Not Available))	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Pelham Eye Center Llc acts as a billing entity for following providers:

Provider Name	Michael S Williams
Provider Type	Practitioner - Optometry
Provider Identifiers	NPI Number: 1962561746 PECOS PAC ID: 0143327890 Enrollment ID: I20070515000266

News Archive

Llama antibodies can detect cerebral lesions that characterize Alzheimer's disease

The major challenge facing physicians treating Alzheimer's is the ability to detect markers of the disease as early as possible. These markers, located in the brain, are difficult to access, hampering diagnosis.

Study finds fewer than half the children receive epinephrine prior to arriving at ED

Anyone suffering a severe allergic reaction (anaphylaxis) should receive epinephrine as quickly as possible. A new study showed that even kids who were prescribed an epinephrine auto injector didn't receive the life-saving medication when they needed it.

CDC, ZKBS classifies Advaxis Agents as non-pathogenic materials

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has received affirmation by the Public Health Service of the U. S. Centers for Disease Control and Prevention and the Zentrale Kommission für die Biologische Sicherheit, the Central Commission for Biological Safety in Germany, that Advaxis strains, constructs and immunotherapies have been attenuated to the point that they are classified as non-pathogenic materials for handling and shipment.

FDA clears Nuvo's IND for Lidocaine Spray formulation

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application filed May 27, 2011 for a novel topical Lidocaine Spray formulation (NRI-ANA), allowing for initiation of Phase 1 studies.

Provider Name	Jennifer Edens Williams
Provider Type	Practitioner - Optometry
Provider Identifiers	NPI Number: 1861708745 PECOS PAC ID: 1658560875 Enrollment ID: I20110104000603

Llama antibodies can detect cerebral lesions that characterize Alzheimer's disease

Study finds fewer than half the children receive epinephrine prior to arriving at ED

CDC, ZKBS classifies Advaxis Agents as non-pathogenic materials

FDA clears Nuvo's IND for Lidocaine Spray formulation

Provider Name	Jason K Dickerson
Provider Type	Practitioner - Optometry
Provider Identifiers	NPI Number: 1487646832 PECOS PAC ID: 2466641543 Enrollment ID: I20110105000166

Llama antibodies can detect cerebral lesions that characterize Alzheimer's disease

Study finds fewer than half the children receive epinephrine prior to arriving at ED

CDC, ZKBS classifies Advaxis Agents as non-pathogenic materials

FDA clears Nuvo's IND for Lidocaine Spray formulation

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Pelham Eye Center Llc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Pelham Eye Center Llc 200 Canyon Park Dr, Pelham, AL 35124-4817 Ph: (205) 910-1750	Pelham Eye Center Llc 200 Canyon Park Dr, Pelham, AL 35124-4817 Ph: (205) 910-1750

News Archive

Llama antibodies can detect cerebral lesions that characterize Alzheimer's disease

Study finds fewer than half the children receive epinephrine prior to arriving at ED

CDC, ZKBS classifies Advaxis Agents as non-pathogenic materials

FDA clears Nuvo's IND for Lidocaine Spray formulation

Optometrist in Pelham, AL

Eyecare Associates, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3429 Pelham Pkwy, Pelham, AL 35124 Phone: 205-663-3937
West Point Optical Group Optometrist Medicare: Not Enrolled in Medicare Practice Location: 325 Huntley Pkwy, Pelham, AL 35124 Phone: 205-624-2015
Dr. Douglas Curtis Clark, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2617 Highway 31 S, Pelham, AL 35124 Phone: 205-664-1575 Fax: 205-664-1578
Kye L Mansfield, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3429 Pelham Pkwy, Pelham, AL 35124 Phone: 205-663-3937
Dr. Kai Rinkowski, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2181 Pelham Parkway, Pelham, AL 35124 Phone: 205-987-0156 Fax: 205-987-0515
Rena C Lewis, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2617 Highway 31 S, Pelham, AL 35124 Phone: 205-664-1575
Dr. James Brandon Perry, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2617 Highway 31 S, Pelham, AL 35124 Phone: 205-664-1575 Fax: 205-664-1578

Pelham Eye Center Llc - Medicare Optometrist in Pelham, AL

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Llama antibodies can detect cerebral lesions that characterize Alzheimer's disease

Study finds fewer than half the children receive epinephrine prior to arriving at ED

CDC, ZKBS classifies Advaxis Agents as non-pathogenic materials

FDA clears Nuvo's IND for Lidocaine Spray formulation

Llama antibodies can detect cerebral lesions that characterize Alzheimer's disease

Study finds fewer than half the children receive epinephrine prior to arriving at ED

CDC, ZKBS classifies Advaxis Agents as non-pathogenic materials

FDA clears Nuvo's IND for Lidocaine Spray formulation

Llama antibodies can detect cerebral lesions that characterize Alzheimer's disease

Study finds fewer than half the children receive epinephrine prior to arriving at ED

CDC, ZKBS classifies Advaxis Agents as non-pathogenic materials

FDA clears Nuvo's IND for Lidocaine Spray formulation

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Llama antibodies can detect cerebral lesions that characterize Alzheimer's disease

Study finds fewer than half the children receive epinephrine prior to arriving at ED

CDC, ZKBS classifies Advaxis Agents as non-pathogenic materials

FDA clears Nuvo's IND for Lidocaine Spray formulation

Optometrist in Pelham, AL